Skip to content
Tirzepatide Report
Provider review

Aspire Health Tirzepatide Review: $49 Care Fee & Vial Costs

Published by Tirzepatide ReportUpdated

On this page

Aspire Health advertises $49 monthly medical care with separately priced compounded tirzepatide/B3 and Zepbound options.

Standout details

  • Public medication prices show the prescribed dose and supply length
  • Free initial consultation and $49 monthly care advertised

Things to consider

  • Medication and lab-test costs are separate from monthly care
  • Vial supply lengths differ; four weeks is not a calendar month

Aspire Health publishes two separate costs for weight-management care: a $49 monthly medical-care fee and medication priced by the prescribed dose and supply. The new-patient consultation is advertised as free. Compounded tirzepatide/B3 starts at $149 for one four-week vial; that is a medication price, not a complete monthly program bill.3,4

The distinction matters because a monthly care fee and a four-week medication supply do not necessarily renew together. Other listed vials contain 4.8, five or 5.3 weeks at the stated weekly dose. Compare the amount due, shipment quantity and next care charge together before choosing a supply.

Care fees and medication prices

The weight-loss page advertises an initial consultation, provider visits every two to three months, lab orders with interpretation and guidance, Slimpossible app access and support between visits. The cost of the lab tests is excluded, although the page says it can be billed to insurance. An order for testing is not the same as an included lab bill or confirmed insurance coverage.3

Medication only

Prescribed weekly doseSingle-vial price and supply
2.5 mg$149; 4 weeks
5 mg$249; 4 weeks
7.5 mg$279; 5.3 weeks
10 mg$289; 5 weeks
12.5 mg$299; 4.8 weeks
15 mg$299; 4 weeks
One-vial medication prices; the $49 monthly care fee and lab costs are separate. Supply depends on the prescribed dose. These are published prices, not dosing instructions.3,4

The medication table is organized by prescribed weekly dose. Multi-vial supplies ship together, and some rows use a double-strength formulation that the provider must review with the patient. A larger purchase changes the upfront commitment; it does not establish a discount, a fixed calendar-month bill or permission to change doses independently.4

Aspire also lists Zepbound at $299 for four weeks at 2.5 mg, $399 at 5 mg and $449 for other doses, with an insurance-dependent pricing qualification. These figures do not establish your coverage, manufacturer-program eligibility or final pharmacy bill. Our Zepbound cost and savings guide explains the branded purchasing questions.4

Who provides care and fills the prescription?

The May 26, 2026 Terms identify Aspire Care LLC doing business as Aspire Health, with Aspire Health AZ LLC or other affiliates involved depending on location and licensure. Those are the service's stated entities. The Terms reserve prescribing decisions to its providers and say enrollment, scheduling or payment alone does not establish a provider-patient relationship or guarantee a prescription.5

The current pages describe licensed providers and pharmacy-prepared compounded medication, but do not identify the pharmacy assigned to a particular prescription. Ask for the dispensing pharmacy, exact preparation and shipment arrangements before purchasing. A company biography, team photograph or pharmacy description does not independently establish a clinician's or pharmacy's credentials.

Service availability depends on the patient's physical location, provider licensure, pharmacy restrictions and state requirements. The homepage describes multiple states; that is not confirmation that every patient in every state can receive every listed treatment. Refills require provider review, with follow-up visits, updated information or testing when requested.5,6

Renewal, cancellation and refunds

Certain services recur until canceled. The Terms say the billing cycle, renewal date and price are disclosed at enrollment, and allow cancellation by emailing info@aspirehealth.care. Cancellation takes effect at the end of the current billing cycle, with no partial-period refund except where required by law. Stopping a subscription and stopping a prescription already being fulfilled are separate questions.5

Commitment and limits

DecisionPublished boundary
Recurring careEmail to cancel; effective end of current cycle
Partial care periodNo refund except where required by law
Paid clinical reviewGenerally non-refundable after service, including treatment denial
Medication shippedFinal sale; pharmacy or shipping-error exception
Refills and lab testsProvider review required; lab-test cost excluded
The May 26, 2026 Terms distinguish recurring care, earned clinical fees and shipped medication. Confirm any additional program-specific agreement.5

For a paid consultation or clinical review, the Terms generally treat the fee as earned after the service, including when the provider declines the requested treatment or finds the patient unsuitable. This does not turn the advertised free initial consultation into a paid one; it defines the policy for applicable paid services. Confirm which fees would actually be charged before review.3,5

Medication sales become final once shipped, with a pharmacy or shipping-error exception limited to replacement or refund of the affected medication. Lab, pharmacy and other third-party charges may have separate policies. Estimated delivery is not guaranteed. Financing also has its own agreement; discontinuing treatment does not automatically discharge the financing obligation.5

Medication evidence and safety

Aspire's compounded tirzepatide/B3 is not an FDA-approved finished drug or a generic equivalent of Zepbound. The clinical trials below do not verify that added ingredient, a particular pharmacy preparation or this practice's patient outcomes. Discuss the intended product and clinical suitability with the prescriber. For background, read our guides to Zepbound side effects, gallbladder risk and the thyroid cancer warning.4

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

Our assessment

Aspire's public medication table and separate care fee make the purchase easier to examine. The important limits are the extra lab bill, different supply lengths, clinician-dependent refills and restricted refunds after services or shipment. Obtain the total for your prescribed supply rather than comparing a single vial with another program's complete recurring price.

For other care models, compare RxSpan MD and LifeMD, keeping each offer's own fees and cancellation rules separate. Our best tirzepatide providers ranking provides additional comparisons.

Frequently asked questions

Is Aspire Health tirzepatide $149 per month?

The $149 price is for one four-week vial of compounded tirzepatide/B3 at the listed 2.5 mg weekly dose. Aspire separately advertises $49 monthly medical care. Other vials have different prices and supply lengths; do not treat a four-week supply as a confirmed calendar-month total.3,4

Are consultations and labs included?

The new-patient consultation is advertised as free. The care offering includes provider visits, lab orders and interpretation, but explicitly excludes the cost of lab tests. The page says those tests can be billed to insurance; coverage is not guaranteed.3

Can I cancel and get my money back?

The Terms allow email cancellation effective at the end of the current billing cycle, with no partial-period refund except as required by law. Applicable paid clinical-service fees are generally earned after service, including treatment denial. Medication sales are final once shipped except for pharmacy or shipping error.5

Does Aspire offer Zepbound as well as compounded tirzepatide?

Its named page lists both Zepbound and compounded tirzepatide/B3. The compounded preparation is not FDA-approved or a generic equivalent of Zepbound. A provider decides whether to prescribe, and your quote should identify the exact product, dispensing pharmacy and supply.4,5

References(6)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. Aspire Health (2026). Weight-loss care, fees and medication pricing (accessed October 24, 2026). Aspire Health.
  4. Aspire Health (2026). Tirzepatide medication pricing and preparation information (accessed October 24, 2026). Aspire Health.
  5. Aspire Health (2026). Terms and Conditions, effective May 26, 2026 (footer modal). Aspire Health.
  6. Aspire Health (2026). Official homepage and service availability (accessed October 24, 2026). Aspire Health.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.